Error loading player: No playable sources found
2530
Novel Observations in IBD
Date
May 18, 2024
SOCIETY: AGA
Presentations:
| MONITORING IBD BY INTESTINAL ULTRASOUND DECREASES TIME TO TREATMENT CHANGE AND TIME TO REMISSION IN COMPARISON TO CONVENTIONAL MANAGEMENT: ANALYSIS OF PATIENTS WITH IBD ON MULTIPLE IBD THERAPIES |
| COST-EFFECTIVENESS OF A BIOMARKER MONITORING STRATEGY COMPARED TO ENDOSCOPIC MONITORING IN LOW-RISK POSTOPERATIVE CROHN’S DISEASE. |
| ONE-YEAR COMPARATIVE EFFECTIVENESS OF UPADACITINIB VERSUS TOFACITINIB FOR ULCERATIVE COLITIS: A MULTICENTER COHORT STUDY |
| MULTIMODAL PREHABILITATION IS ASSOCIATED WITH IMPROVED SURGICAL OUTCOMES IN IBD |
| NATURAL HISTORY OF PRESUMED ISOLATED CROHN'S DISEASE PERIANAL FISTULA |
| BOWEL HABITS AND QUALITY OF LIFE IN ULCERATIVE COLITIS PATIENTS UNDERGOING J POUCH CONSTRUCTION: A RETROSPECTIVE ANALYSIS AT 6- AND 12-MONTHS POST-FUNCTIONALIZATION |
Moderators
Vanderbilt University Medical Center
Mayo Foundation for Medical Education and Research
Tracks
Related Products
IBD Controlled Trials II
SOCIETY: AGA This session is the second session of the ever-popular and clinically impactful clinical trials sessions in IBD. Insights into novel agents including obefazimod, VTX002. MH002, risankizumab, and mirikizumab will be presented…
IMIBD Late Breakers and Innovations in IBD
SOCIETY: AGA By popular demand, this new session highlights the best late-breakers submitted to the IBD section and well as innovations in technology and new paradigms of care in IBD
IBD Diagnosis. Monitoring, and Prediction of Complications
SOCIETY: AGA This session highlights the latest research on novel prediction models in IBD as well as the role of the fecal microbiome and imaging in IBD…
Role of the Environment in IBD
SOCIETY: AGA As our scientific tools improve, so does our ability to link the environment with different aspects of IBD…
